SIM
BIO icon

Spark Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Spark Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19,400
Closed -$6.07M – 674
2018
Q3 		$6.07M Hold
19,400
– – 0.35% 81
2018
Q2 		$5.6M Buy
19,400
+14,100
+266% +$3.89M 0.33% 92
2018
Q1 		$1.32M Sell
5,300
-15,600
-75% -$3.97M 0.08% 294
2017
Q4 		$4.99M Hold
20,900
– – 0.27% 112
2017
Q3 		$4.64M Sell
20,900
-26,500
-56% -$5.96M 0.25% 137
2017
Q2 		$10.7M Hold
47,400
– – 0.66% 15
2017
Q1 		$9.45M Buy
47,400
+33,200
+234% +$6.39M 0.6% 18
2016
Q4 		$2.59M Buy
+14,200
New +$2.42M 0.21% 154
2015
Q3 		– Sell
-14,800
Closed -$2.23M – 674
2015
Q2 		$2.23M Sell
14,800
-5,200
-26% -$744K 0.31% 92
2015
Q1 		$2.7M Hold
20,000
– – 0.38% 65
2014
Q4 		$2.41M Hold
20,000
– – 0.41% 63
2014
Q3 		$2.27M Hold
20,000
– – 0.34% 86
2014
Q2 		$2.39M Sell
20,000
-3,100
-13% -$379K 0.36% 79
2014
Q1 		$2.96M Hold
23,100
– – 0.46% 46
2013
Q4 		$2.85M Sell
23,100
-4,100
-15% -$500K 0.49% 33
2013
Q3 		$3.2M Hold
27,200
– – 0.73% 16
2013
Q2 		$3.05M Buy
+27,200
New +$3.19M 0.82% 17

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Spark Investment Management's BIO Position: Q4 2018 in Review

Spark Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2018, closing a stake of 19,400 shares — an estimated $6.07M sold.

Spark Investment Management first reported a position in BIO in Q2 2013 and held it in 17 quarters. The position peaked at $10.7M in Q2 2017. 329 funds tracked by Wall St. Rank hold BIO as of Q4 2018.

  • Spark Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2018 after selling out during the quarter.
  • Spark Investment Management sold 19,400 Bio-Rad Laboratories Class A shares in Q4 2018, an estimated $6.07M.
  • Spark Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 17 quarters.
  • Spark Investment Management's Bio-Rad Laboratories Class A position peaked at $10.7M in Q2 2017.
  • 329 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.